Associated Papers
DNA damage response mutations enhance the antitumor efficacy of ATR and PARP inhibitors in cholangiocarcinoma cell lines.
Lerksuthirat T et al.
Oncology Letters, 2025
39822940 (PubMed )
Supplement: Supplementary_Data3.xlsx › SiSP-K01
Identification of potentially deleterious mutations in gastric cancer using patient-derived xenograft models.
Kong L et al.
Frontiers in Genetics, 2025
41696640 (PubMed )
Supplement: Supplementaryfile1.zip › 20260103_SupMaterial › Supplementary_Table_S4.XLSX › Sheet1
Genomic Analysis of Cutaneous CD30-Positive Lymphoproliferative Disorders.
Abdulla FR et al.
Jid Innovations : Skin Science From Molecules to Population Health, 2022
34977845 (PubMed )
Supplement: mmc1.xlsx › Table_1
Select a paper to view details